The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparing the effectiveness of IO-based combination regimens as first-line treatment for advanced clear-cell renal cell carcinoma (ccRCC).
 
Ramona Stelmach
Honoraria - Eisai
Consulting or Advisory Role - Amgen; Eisai; Pfizer
Travel, Accommodations, Expenses - Astellas Pharma; Ipsen
 
Stefanie Zschaebitz
Honoraria - Amgen; Astellas Pharma; Bayer; BMS GmbH & Co. KG; Eisai Germany; Ipsen; Janssen Oncology; Merck Serono; MSD Oncology; Novartis; Pfizer (Inst)
Consulting or Advisory Role - Amgen; Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Eisai; EUSA Pharma; Gilead Sciences; Ipsen; Merck; MSD Oncology; Pfizer (Inst); Roche; Sanofi/Aventis (Inst)
Research Funding - Eisai (Inst)
Travel, Accommodations, Expenses - Amgen; Astellas Pharma; BMS GmbH & Co. KG; Ipsen; Janssen Oncology; Merck; Pfizer
 
Stella Erdmann
No Relationships to Disclose
 
Katrin Schlack
Honoraria - AAA HealthCare; Amgen (Inst); Astellas Pharma; AstraZeneca; Bayer Germany; Eisai Germany; Fosanis; Ipsen; Janssen; Merck Serono; MSD; Novartis; Pfizer
Consulting or Advisory Role - Apogepha; Bayer; BMS GmbH & Co. KG; Ipsen; Janssen; Pfizer
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Ipsen; Janssen; Pfizer
 
Linus Materna
No Relationships to Disclose
 
Thomas Hilser
Honoraria - Ipsen
 
Philipp Ivanyi
Stock and Other Ownership Interests - BB Biotech Ventures
Honoraria - AIMM Therapeutics; AstraZeneca; Bayer/Vital; Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Merck Serono; MSD Oncology; Roche Pharma AG
Consulting or Advisory Role - Bayer/Vital; Bristol-Myers Squibb; ClinSol; Deciphera; Eisai; EUSA Pharma; Ipsen; Merck Serono; MSD; Pfizer
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; Merck Serono
Other Relationship - Merck Serono; Pfizer
(OPTIONAL) Uncompensated Relationships - AIO-Studien; German Cancer Society
 
Margitta Retz
No Relationships to Disclose
 
Jozefina Casuscelli
Research Funding - AstraZeneca (Inst); MSD Oncology (Inst)
Expert Testimony - Astellas Pharma; Janssen Cilag; MSD Oncology
Travel, Accommodations, Expenses - Bayer; Janssen Oncology; Merck KGaA; Pfizer
 
Pia Paffenholz
Honoraria - Apogepha; Astellas Pharma; AstraZeneca; BMS GmbH & Co. KG; Eisai; Ipsen; Janssen; Merck; Novartis
Consulting or Advisory Role - AstraZeneca; BMS GmbH & Co. KG; Ipsen; Janssen; Merck; MSD; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Ipsen; Janssen; Medac; Merck
 
Marco Schnabel
Stock and Other Ownership Interests - BioNTech SE
Honoraria - Apogepha; Astellas Pharma; AstraZeneca; AstraZeneca (Inst); Bayer; Gilead Sciences; Ipsen; Ipsen (Inst); Johnson & Johnson/Janssen; Johnson & Johnson/Janssen (Inst); Medac; Merck Serono; MSD Oncology; MSD Oncology (Inst); Novartis; Pfizer
Consulting or Advisory Role - AstraZeneca; Bayer; Bayer; Gilead Sciences; Ipsen; Johnson & Johnson/Janssen; MSD Oncology; Novartis; Pfizer
Travel, Accommodations, Expenses - Ipsen; Johnson & Johnson/Janssen; Pfizer
 
Timo Egenolf
No Relationships to Disclose
 
Arne Strauß
Honoraria - Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Merck; MSD; Pfizer
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Merck; MSD; Pfizer
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Ipsen (Inst); Merck (Inst); MSD (Inst); Pfizer (Inst); Seagen (Inst)
 
Richard Cathomas
Honoraria - Astellas Pharma (Inst); Janssen-Cilag; Merck KGaA (Inst); Sandoz (Inst)
Consulting or Advisory Role - Accord Healthcare (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Ipsen (Inst); Janssen-Cilag; MSD Oncology (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca (Inst); Ipsen (Inst)
 
Berna Özdemir
Consulting or Advisory Role - BMSi (Inst); Ipsen (Inst); Merck/Pfizer (Inst); MSD (Inst); Novartis (Inst); Sanofi (Inst)
Speakers' Bureau - BMSi (Inst)
 
Anton Moderegger
No Relationships to Disclose
 
Stephanie Neuberger
Honoraria - Janssen; Merck; Pfizer
Consulting or Advisory Role - Merck
Travel, Accommodations, Expenses - Pfizer
 
Florian Roghmann
Consulting or Advisory Role - Astellas Pharma (Inst); BMS (Inst); Janssen (Inst); Merck (Inst); Merck Serono (Inst); Pfizer; Roche (Inst)
Travel, Accommodations, Expenses - Janssen (Inst); Merck Serono (Inst)
 
Viktor Grünwald
Employment - University Hospital Essen
Stock and Other Ownership Interests - AstraZeneca; Bicycle Therapeutics; Bristol-Myers Squibb; Genmab; MSD
Honoraria - Advanced Accelerator Applications/Novartis; Amgen; Apogepha; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Eisai; Ipsen; Janssen-Cilag; Merck Serono; MSD Oncology; Ono Pharmaceutical; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Cureteq; Debiopharm Group; Eisai; Gilead Sciences; Ipsen; Janssen-Cilag; MSD Oncology; Novartis; Oncorena; PCI Biotech; Pfizer; Synthekine
Research Funding - Amgen (Inst); Bicycle Therapeutics (Inst); BMS (Inst); Gilead Sciences (Inst); Ipsen (Inst); MSD Oncology (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; Janssen; Merck Serono; Pfizer
 
Christopher Darr
Stock and Other Ownership Interests - Bayer
Honoraria - Bayer; Ipsen; Janssen; MSD
Consulting or Advisory Role - Bayer; Ipsen; Janssen
Research Funding - Deutsche Forschungsgemeinschaft (Inst)
Travel, Accommodations, Expenses - Bayer; Ipsen; Janssen; Xeos medical
 
GUARDIAN study group
No Relationships to Disclose